Stock Market News: Economy, Policy & Company Updates
EquityTimer summarises official corporate filings and market announcements into short, factual updates you can read in seconds. Every card is drawn directly from primary sources — BSE corporate announcements in India and SEC filings in the US — covering results, dividends, mergers, management changes and regulatory actions. Summaries are checked against the original document before publication, and each card links back to the filing so you can read it in full.
- All 360
- Management 104
- Results 81
- M&A 56
- Agreement 53
- Debt 45
- Regulatory 11
- Ownership 6
- Corpaction 3
- Accounting 1
India Ratings upgrades Glenmark’s long‑term bank loans to IND AA+ with stable outlook
India Ratings and Research raised Glenmark Pharmaceuticals’ long‑term bank loan rating to IND AA+ from IND AA, maintaining a stable outlook, and affirmed its short‑term loan rating at IND A1+. The upgrade followed the recognition of USD 560 million from an ISB 2001 licensing deal and covers INR 18,500 million and INR 23,500 million of bank facilities.
Reliance Industries received AAA/Stable credit ratings from CARE and CRISIL
Reliance Industries Limited disclosed that CARE Ratings and CRISIL both assigned the company a AAA rating with a Stable outlook on September 9 2026. The ratings cover non‑convertible debentures totaling ₹15,000 crore (assigned) and additional issues of ₹6,500 crore, ₹5,500 crore and ₹20,000 crore (reaffirmed), as well as ₹34,500 crore of commercial paper (reaffirmed).
Sun Pharma gets Moody’s Baa1 and S&P BBB+ ratings, cites $11.75 bn Organon deal
Sun Pharmaceutical Industries Ltd received investment‑grade international issuer ratings of Baa1 from Moody’s and BBB+ from S&P Global, both with stable outlooks. The ratings reflected its proposed $11.75 billion acquisition of Organon & Co., which Moody’s expects to generate about $350 million of cost synergies and temporarily raise pro‑forma gross debt/EBITDA leverage to around 3.0× by March 2027.
Canara Bank received ICRA AA+ reaffirmation on Rs 11,000 cr Tier I bonds and AA+ assignment on Rs 4,500 cr Tier I bonds
On September 8 2026, ICRA reaffirmed Canara Bank’s AA+ rating (Stable) for existing Basel III Tier I bonds worth Rs 11,000 cr and assigned a new AA+ rating (Stable) to Tier I bonds of Rs 4,500 cr. The agency also reaffirmed an AAA rating (Stable) for Tier II bonds of Rs 8,500 cr and an A1+ rating (Stable) for certificates of deposit of Rs 20,000 cr.
India Ratings affirms Mahindra & Mahindra and its debt instruments at IND AAA/Stable/IND A1+
On 7 September 2026, India Ratings and Research reaffirmed Mahindra & Mahindra Ltd.’s overall credit rating at IND AAA with a Stable outlook. The agency also affirmed the rating of its non‑convertible debentures (INR 4,750 million) and bank loan facilities (INR 13,025 million) at IND AAA/Stable/IND A1+.
REC Limited’s long‑term credit rating upgraded to A‑ by JCR
REC Limited disclosed that Japan Credit Rating Agency, Ltd. (JCR) revised its long‑term issuer credit rating to “A‑” with a Stable outlook, up from “BBB+” with a Stable outlook. The filing was submitted on September 7, 2026, in compliance with SEBI Listing Regulations.
Shree Cement’s ₹1,000 cr commercial paper rating reaffirmed at A1+ by CARE Ratings
Shree Cement Limited disclosed that CARE Ratings Limited reaffirmed its credit rating of A1+ for the company’s commercial paper issuance of ₹1,000.00 crores. The reaffirmation was reported in a company update filed with the BSE on 7 September 2026, complying with SEBI’s Regulation 30 disclosure requirements.
L&T’s NCDs, bank loans and commercial paper reaffirmed at top CRISIL ratings
Larsen & Toubro Limited disclosed that on September 3, 2026 CRISIL Ratings Limited reaffirmed its non‑convertible debentures at a CRISIL AAA rating with a Stable outlook. The agency also reaffirmed the company’s bank loan facilities and fixed deposits at CRISIL AAA/Stable and its commercial paper at CRISIL A1+. The rating details were published on CRISIL’s website.
Shree Cement’s ₹1,000 crore commercial paper rating reaffirmed at Crisil A1+
Shree Cement Limited disclosed that CRISIL Ratings Limited reaffirmed its credit rating of A1+ for the company’s commercial paper issuance of ₹1,000.00 crores. The reaffirmation was reported in a company update filed on 4 September 2026, complying with SEBI’s Regulation 30 disclosure requirements.
India Ratings upgrades Glenmark’s long‑term bank loans to IND AA+ with stable outlook
India Ratings and Research raised Glenmark Pharmaceuticals’ long‑term bank loan rating to IND AA+ from IND AA, maintaining a stable outlook, and affirmed its short‑term loan rating at IND A1+. The upgrade followed the recognition of USD 560 million from an ISB 2001 licensing deal and covers INR 18,500 million and INR 23,500 million of bank facilities.
Reliance Industries received AAA/Stable credit ratings from CARE and CRISIL
Reliance Industries Limited disclosed that CARE Ratings and CRISIL both assigned the company a AAA rating with a Stable outlook on September 9 2026. The ratings cover non‑convertible debentures totaling ₹15,000 crore (assigned) and additional issues of ₹6,500 crore, ₹5,500 crore and ₹20,000 crore (reaffirmed), as well as ₹34,500 crore of commercial paper (reaffirmed).
Sun Pharma gets Moody’s Baa1 and S&P BBB+ ratings, cites $11.75 bn Organon deal
Sun Pharmaceutical Industries Ltd received investment‑grade international issuer ratings of Baa1 from Moody’s and BBB+ from S&P Global, both with stable outlooks. The ratings reflected its proposed $11.75 billion acquisition of Organon & Co., which Moody’s expects to generate about $350 million of cost synergies and temporarily raise pro‑forma gross debt/EBITDA leverage to around 3.0× by March 2027.
Canara Bank received ICRA AA+ reaffirmation on Rs 11,000 cr Tier I bonds and AA+ assignment on Rs 4,500 cr Tier I bonds
On September 8 2026, ICRA reaffirmed Canara Bank’s AA+ rating (Stable) for existing Basel III Tier I bonds worth Rs 11,000 cr and assigned a new AA+ rating (Stable) to Tier I bonds of Rs 4,500 cr. The agency also reaffirmed an AAA rating (Stable) for Tier II bonds of Rs 8,500 cr and an A1+ rating (Stable) for certificates of deposit of Rs 20,000 cr.
India Ratings affirms Mahindra & Mahindra and its debt instruments at IND AAA/Stable/IND A1+
On 7 September 2026, India Ratings and Research reaffirmed Mahindra & Mahindra Ltd.’s overall credit rating at IND AAA with a Stable outlook. The agency also affirmed the rating of its non‑convertible debentures (INR 4,750 million) and bank loan facilities (INR 13,025 million) at IND AAA/Stable/IND A1+.
REC Limited’s long‑term credit rating upgraded to A‑ by JCR
REC Limited disclosed that Japan Credit Rating Agency, Ltd. (JCR) revised its long‑term issuer credit rating to “A‑” with a Stable outlook, up from “BBB+” with a Stable outlook. The filing was submitted on September 7, 2026, in compliance with SEBI Listing Regulations.
Shree Cement’s ₹1,000 cr commercial paper rating reaffirmed at A1+ by CARE Ratings
Shree Cement Limited disclosed that CARE Ratings Limited reaffirmed its credit rating of A1+ for the company’s commercial paper issuance of ₹1,000.00 crores. The reaffirmation was reported in a company update filed with the BSE on 7 September 2026, complying with SEBI’s Regulation 30 disclosure requirements.
L&T’s NCDs, bank loans and commercial paper reaffirmed at top CRISIL ratings
Larsen & Toubro Limited disclosed that on September 3, 2026 CRISIL Ratings Limited reaffirmed its non‑convertible debentures at a CRISIL AAA rating with a Stable outlook. The agency also reaffirmed the company’s bank loan facilities and fixed deposits at CRISIL AAA/Stable and its commercial paper at CRISIL A1+. The rating details were published on CRISIL’s website.
Shree Cement’s ₹1,000 crore commercial paper rating reaffirmed at Crisil A1+
Shree Cement Limited disclosed that CRISIL Ratings Limited reaffirmed its credit rating of A1+ for the company’s commercial paper issuance of ₹1,000.00 crores. The reaffirmation was reported in a company update filed on 4 September 2026, complying with SEBI’s Regulation 30 disclosure requirements.
